Belzutifan treatment for von Hippel-Lindau (VHL) disease–associated central nervous system (CNS) hemangioblastomas (HBs) in the phase 2 LITESPARK-004 study. Prognostic evaluation of surgical ...
Analytical validation of the Labcorp Plasma Complete test to enable precision oncology through solid tumor liquid biopsy comprehensive genomic profiling. This is an ASCO Meeting Abstract from the 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results